{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:43:37Z","timestamp":1770511417208,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":577,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1002\/2327-6924.12046","type":"journal-article","created":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T07:33:43Z","timestamp":1373614423000},"page":"85-90","source":"Crossref","is-referenced-by-count":21,"title":["Statins\u2019 effect on plasma levels of Coenzyme Q10 and improvement in myopathy with supplementation"],"prefix":"10.1097","volume":"26","author":[{"given":"Nate","family":"Littlefield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renea L.","family":"Beckstrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karlen E.","family":"Luthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"8","key":"R1-5-20210915","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2165\/00002018-200629080-00007","article-title":"Effect of ezetimibe andor simvastatin on coenzyme q10 levels in plasma.","volume":"29","author":"Berthold","year":"2006","journal-title":"Drug Safety"},{"issue":"10","key":"R2-5-20210915","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","article-title":"Effect of coenzyme q10 on mypathic symptoms in patients treated with statins.","volume":"99","author":"Caso","year":"2007","journal-title":"American Journal of Cardiology"},{"key":"R3-5-20210915","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/biof.5520280304","article-title":"Effect of atorvastatin withdrawal on circulating coenzyme q10 concentration in patients with hypercholesterolemia.","volume":"28","author":"Chu","year":"2006","journal-title":"Biofactors"},{"key":"R4-5-20210915","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11883-010-0120-9","article-title":"Evidencebased management of statin myopathy.","volume":"12","author":"Harper","year":"2010","journal-title":"Current Atherosclerosis Reports"},{"issue":"1","key":"R5-5-20210915","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1093\/hmg\/ddg072","article-title":"Disorders of cholesterol biosynthesis: Prototypic metabolic malformation syndromes.","volume":"12","author":"Herman","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"R6-5-20210915","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative review: Statinrelated myopathy.","volume":"150","author":"Joy","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"R7-5-20210915","first-page":"2","article-title":"The role of coenzyme Q10 in statinassociated myopathy.","volume":"1","author":"Kalra","year":"2009","journal-title":"Electronic Physician"},{"key":"R8-5-20210915","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.numecd.2006.09.011","article-title":"Coenzyme Q10 in patients undergoing CABG: Effect of statins and nutritional supplementation.","volume":"18","author":"Keith","year":"2008","journal-title":"Nutrition, Metabolism Cardiovascular Diseases"},{"key":"R9-5-20210915","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0b013e32830e2774","article-title":"Druginduced myopathies.","volume":"21","author":"Klopstock","year":"2008","journal-title":"Current Opinion in Neurology"},{"key":"R10-5-20210915","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archneur.62.11.1709","article-title":"Muscle coenzyme q10 level in statinrelated myopathy.","volume":"62","author":"Lamperti","year":"2005","journal-title":"Archives of Neurology"},{"key":"R11-5-20210915","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/biof.5520250116","article-title":"Treatment of statin adverse effects with supplemental coenzyme q10 and statin drug discontinuation.","volume":"25","author":"Langsjoen","year":"2005","journal-title":"Biofactors"},{"key":"R12-5-20210915","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.mito.2007.03.002","article-title":"Coenzyme Q10 and statins: Biochemical and clinical implications.","volume":"7S","author":"Littarru","year":"2007","journal-title":"Mitochondrion"},{"issue":"2","key":"R13-5-20210915","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5551\/jat.12.111","article-title":"Reduction of serum ubiquinol10 and ubiquinone10 levels by atorvastatin in hypercholesterolemic patients.","volume":"12","author":"Mabuchi","year":"2005","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"issue":"23","key":"R14-5-20210915","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme q10 in statinassociated myopathy.","volume":"49","author":"Marcoff","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"key":"R15-5-20210915","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11883-010-0134-3","article-title":"Coenzyme q10 and statin myalgia: What is the evidence?","volume":"12","author":"Mas","year":"2010","journal-title":"Current Atherosclerosis Reports"},{"key":"R16-5-20210915","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bmj.a2286","article-title":"Statin induced myopathy.","volume":"337","author":"Sathasivam","year":"2008","journal-title":"British Medical Journal"},{"issue":"6","key":"R17-5-20210915","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MOL.0b013e3283168ecd","article-title":"Effects of ubiquinone (coenzyme q10) on myopathy in statin users.","volume":"19","author":"Schaars","year":"2008","journal-title":"Current Opinion in Lipidology"},{"key":"R18-5-20210915","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/biof.5520090218","article-title":"Distribution of antioxidants among blood components and lipoproteins: Significance of lipidsCoQ10 ratio as a possible marker of increased risk for atherosclerosis.","volume":"9","author":"Tomasetti","year":"1999","journal-title":"Biofactors"},{"issue":"9","key":"R20-5-20210915","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.amjcard.2007.06.030","article-title":"Effect of coenzyme q10 supplementation on simvastatin induced myalgia.","volume":"100","author":"Young","year":"2007","journal-title":"American Journal of Cardiology"}],"container-title":["Journal of the American Association of Nurse Practitioners"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2F2327-6924.12046","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01741002-201402000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T13:46:20Z","timestamp":1631713580000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01741002-201402000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/2327-6924.12046","relation":{},"ISSN":["2327-6924"],"issn-type":[{"value":"2327-6924","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}